UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach

Drug safety, 2023-10, Vol.46 (10), p.921-926

2023

Volltextzugriff (PDF)

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis

Drug safety, 2020-12, Vol.43 (12), p.1277-1285

2020

Volltextzugriff (PDF)

Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies

Drug safety, 2016-12, Vol.39 (12), p.1175-1187

2016

Volltextzugriff (PDF)

Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance

Drug safety, 2020-11, Vol.43 (11), p.1191-1194

2020

Volltextzugriff (PDF)

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Drug safety, 2023-09, Vol.46 (9), p.819-833

2023

Volltextzugriff (PDF)

Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals

Drug safety, 2024-11, Vol.47 (11), p.1061-1074

2024

Volltextzugriff (PDF)

Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS

Drug safety, 2024-03, Vol.47 (3), p.271-284

2024

Volltextzugriff (PDF)

Authors’ Reply to Robert P. Giugliano and Colleagues’ Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”

Drug safety, 2021-04, Vol.44 (4), p.505-506

2021

Volltextzugriff (PDF)

Authors’ Reply to Cappello et al. Comment on: “Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System”

Drug safety, 2023-09, Vol.46 (9), p.919-920

2023

Volltextzugriff (PDF)

Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Drug safety, 2022-08, Vol.45 (8), p.891-908

2022

Volltextzugriff (PDF)

Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study

Drug safety, 2023-09, Vol.46 (9), p.857-866

2023

Volltextzugriff (PDF)

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database

Drug safety, 2022-12, Vol.45 (12), p.1539-1549

2022

Volltextzugriff (PDF)

Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study

BMC pharmacology & toxicology, 2019-11, Vol.20 (1), p.65-65, Article 65

2019

Volltextzugriff (PDF)

Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome

Expert opinion on drug metabolism & toxicology, 2014-02, Vol.10 (2), p.293-305

2014

Volltextzugriff (PDF)

Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews

Drug safety, 2019-12, Vol.42 (12), p.1409-1422

2019

Volltextzugriff (PDF)

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database

Drug safety, 2013-06, Vol.36 (6), p.467-479

2013

Volltextzugriff (PDF)

Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

Drug safety, 2022-06, Vol.45 (6), p.663-673

2022

Volltextzugriff (PDF)

The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco‐toxicological data to assess and potentially mitigate their diffusion to water supplies

British journal of clinical pharmacology, 2023-07, Vol.89 (7), p.2020-2027

2023

Volltextzugriff (PDF)

Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database

Drug safety, 2024-08, Vol.47 (8), p.745-757

2024

Volltextzugriff (PDF)

Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis

Drug safety, 2024-07, Vol.47 (7), p.601-605

2024

Volltextzugriff (PDF)

Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice

Drug safety, 2017-06, Vol.40 (6), p.461-464

2017

Volltextzugriff (PDF)

Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System

Drug safety, 2023-03, Vol.46 (3), p.283-295

2023

Volltextzugriff (PDF)

Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems

Drug safety, 2018-08, Vol.41 (8), p.745-752

2018

Volltextzugriff (PDF)

Antimicrobials and the Risk of Torsades de Pointes: The Contribution from Data Mining of the US FDA Adverse Event Reporting System

Drug safety, 2010-04, Vol.33 (4), p.303-314

2010

Volltextzugriff (PDF)

Recurrence of pericarditis after influenza vaccination: a case report and review of the literature

BMC pharmacology & toxicology, 2018-05, Vol.19 (1), p.20-5, Article 20

2018

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaToxicology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)
Buchkapitel
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Pharmacology & Pharmacy
(37)
Drug Safety And Pharmacovigilance
(30)
Medicine
(30)
Medicine & Public Health
(30)
Pharmacology/toxicology
(30)
Public, Environmental & Occupational Health
(30)
Humans
(25)
Original Research Article
(15)
Pharmacovigilance
(15)
Drugs
(9)
Male
(9)
Original
(9)
Adverse Drug Reaction Reporting Systems
(6)
Drug Dosages
(6)
Female
(6)
United States Food And Drug Administration
(6)
Confidence Intervals
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis

Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies

Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals

Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS

Authors’ Reply to Robert P. Giugliano and Colleagues’ Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”

Authors’ Reply to Cappello et al. Comment on: “Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System”

Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database

Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study

Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome

Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database

Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco‐toxicological data to assess and potentially mitigate their diffusion to water supplies

Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database

Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis

Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice

Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System

Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems

Antimicrobials and the Risk of Torsades de Pointes: The Contribution from Data Mining of the US FDA Adverse Event Reporting System

Recurrence of pericarditis after influenza vaccination: a case report and review of the literature

Aktive Filter

Suchergebnisse filtern